Related Experiment Video
Updated: Jan 14, 2026

04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
785
Managing fatigue in Parkinson's disease: Preparing for a randomized controlled trial
Neda Alizadeh1,2, Tanya Packer1,3,4,5, Ingrid Sturkenboom6
1School of Occupational Therapy, Faculty of Health, Dalhousie University, Halifax, Canada.
Journal of Parkinson'S Disease
|October 17, 2025
Summary
This pilot study suggests the Packer Managing Fatigue program may improve satisfaction with performance in Parkinson's disease (PD) patients. Further research is needed to confirm these findings for managing PD fatigue.
Area of Science:
- Neurology
- Occupational Therapy
- Rehabilitation Science
Background:
- Fatigue is a prevalent and impactful symptom in Parkinson's disease (PD), yet it is often under-researched and undertreated.
- Effective interventions are crucial to improve the quality of life for individuals with PD experiencing severe fatigue.
Purpose of the Study:
- To evaluate the feasibility and preliminary effectiveness of an individual videoconference version of the Packer Managing Fatigue program for people with PD.
- To gather data informing the design of a larger, definitive randomized controlled trial.
Main Methods:
- A two-arm, assessor-masked, randomized controlled pilot study.
- Recruited participants with PD experiencing severe fatigue, possessing English proficiency and internet access.
- Assessed outcomes including occupational performance, satisfaction, occupational balance, fatigue impact, quality of life, and sleep using mixed repeated-measures ANOVA and non-parametric tests.
Main Results:
- A trend towards significant improvement in satisfaction with performance was observed in the intervention group compared to usual care (p=0.09).
- Significant improvement in satisfaction with performance was found within the intervention group (p=0.04) with a moderate effect size.
- Small to moderate effect sizes were noted for occupational balance and performance, and Multidimensional Fatigue Inventory subscales.
Conclusions:
- Preliminary evidence suggests the Packer Managing Fatigue program may offer benefits for individuals with Parkinson's disease.
- The study provides valuable insights into recruitment and effect sizes for future, larger trials.
- Further rigorous research is necessary to definitively establish the program's effectiveness in managing PD-related fatigue.
Related Concept Videos
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

